After Hours Summary: VRTU -24%, DDS -7.5%, ZTO -4%, CSCO +2.5%, NTES +2% among earnings / guidance moversAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: TRQ +5.5%, FLO +3.7% (light volume), CSCO +2.5%, NTES +1.9%
Companies trading higher in after hours in reaction to news: AGIO +14% (announces Phase 3 ClarIDHy trial of TIBSOVO achieved its primary endpoint), MGNX +14% (SOPHIA phase 3 breast cancer ASCO abstract released), CHRA +11.7% (after closing 40% lower on the day), VSTM +1.9% (light volume; to present new COPIKTRA dose modification data from patients treated in the Phase 3 DUO study - dose interruptions of a median 15 days do not significantly impact response or PFS), HOME +0.9% (after spiking higher in late trade on Kohl's [KSS] M&A speculation), DRE +0.8% initiated with Buy at Goldman), TGP +0.6% (ticking higher; David Einhorn's Greenlight discloses new position), CELG +0.4% (Third Point, Paulson & Co, Baupost, and Corvex all disclosed new CELG positions)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: VRTU -24.0%, DDS -7.5%, ZTO -4.3%, FTCH -4.1%, DRYS -2.3%
Companies trading lower in after hours in reaction to news: PLYM -9.6% (proposed offering of 3 mln shares of common stock), ADRO -8.5% (updates clinical development programs for BION-1301), ADMA -8.3% (announces proposed public offering of $45 mln of its common stock), EOLS -7.9% (ALPHAEON agreed to sell ~4.0 mln shares of common stock in Evolus in an underwritten public offering), DZSI -4.8% (launches underwritten registered public offering of common stock), ABR -3.7% (announces public offering of 8.0 mln shares of common stock), NKTR -3.7% (light volume; announced five abstracts accepted for presentation at ASCO), OSTK -1.5% (extending weakness seen in afternoon trading - after CEO Patrick Byrne disclosed the sale of 500K shares), UBER -1.3% (pulling back after closing the last two sessions higher
